Authors
Latest:
Closing Thoughts From The Panel On Pneumococcal VaccinationThe panel of pneumococcal vaccination experts offer their concluding insights and perspectives on the current landscape of pneumococcal vaccines.
Latest:
Variation in the Coverage of Disease-Modifying Multiple Sclerosis Drugs Among US PayersAn examination of payer coverage for multiple sclerosis drugs shows variation in how these drugs are covered and in the evidence that payers review to make these decisions.
Latest:
340B Recertification: Annual Opportunity to Ensure 340B Program ComplianceThe 340B Drug Pricing Program requires covered entities to ensure program integrity through several processes.
Latest:
Applying Value-Based Incentive Models Within Community Pharmacy PracticeHealthcare is transforming through new payment models, including value-based incentives (VBIs); this article discusses implementation principles and operational strategies for VBIs in community pharmacy practice.
Latest:
Assessing the Association Between Medication Adherence and Glycemic ControlAmong a population of adult patients with type 2 diabetes, adherence to oral hypoglycemic medications is independently associated with poor glycemic control, even after adjusting for patient-level covariates.
Latest:
Strategies to Overcome the Readmission Crisis in Health SystemsHealth care is in the midst of a transformation in which health care providers are increasingly being paid for value provided rather than per service.
Latest:
Lodoco: A New Indication for an Old DrugHistorically, colchicine has been used primarily in the management of gout; however, in 2023, the FDA approved Lodoco, a newly marketed colchicine product, for the management of cardiovascular disease.
Latest:
Viability of a Dose Optimization Program Within a Specialty PharmacyDose optimization strategies offer a potentially valid, clinically based intervention in which payers can realize a direct drug cost savings, and indirect medical cost avoidance.
Latest:
Oral Oncology: Utilization of Selected Oral Antineoplastic Enzyme Inhibitor AgentsAn overview of the utilization and cost for selected oral antineoplastic agents, with discussion regarding oncology in general, as well as the topic of adherence.
Latest:
Where Is Independent Pharmacy Headed?Several recent studies, blogs and articles have raised a question in my mind about how secure independant pharmacy practice is.
Latest:
The Farm Bill and Low-THC Hemp in IndianaIndiana’s chaotic hemp policy leaves consumers confused.
Latest:
Irritated About Your Irritable Bowels? Confronting Ulcerative ColitisThe symptoms of ulcerative colitis can cause embarrassment and pain, but pharmacists' expert advice can help ease the discomfort.
Latest:
Factors Associated With Employee Participation in a Value-Based Insurance Design InitiativeWe describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.
Latest:
Combination Therapy Shows Promise in Lung CancerDurvalumab and tremelimumab demonstrated antitumor activity in patients with non-small cell lung cancer regardless of PD-L1 status.
Latest:
Treatment of Diabetes and Angioedema RiskPharmacists must be aware of potentially serious adverse reactions in patients receiving angiotensin- converting enzyme therapy, particularly with the concurrent use of dipeptidly peptidase IV inhibitors.
Latest:
Juvenile Diabetes Rates IncreasePediatric diabetes and pediatric diabetic nephropathy rates significantly increase at age 12.
Latest:
Rehospitalizations and Direct Medical Costs for cSSSI: Linezolid Versus VancomycinAmong commercially insured patients treated with linezolid or vancomycin following cSSSI-related hospitalization, linezolid was associated with significantly lower rehospitalization rates and total direct medical costs.
Latest:
Exploring the Versatility of Azelaic Acid in Facial Acne, Truncal Acne, Photoaging, and MelasmaContinuing education activity featured in the March 2018 edition of Pharmacy Times.
Latest:
Opportunities for Collaboration in Clinical Pharmacy ServicesAs the relationship between pharmacist and physician developed, doctors began asking the pharmacist to go beyond offering advice and to initiate changes to the drug and dosage regimens in response to patients' signs and symptoms.
Latest:
The Impact of Abuse Deterrent Technologies on Prescription Opioid TrendsThe authors examined trends in the utilization of prescription opioid medication following introduction of abuse deterrent technology for Oxycontin.
Latest:
Pharmacists Are Key to Addressing Flu Vaccine HesitancyA strong recommendation from trusted health care professionals can make a difference.
Latest:
Exploring Nursing Adherence Programs for Oral OncolyticsSpecialty pharmacies are becoming more involved in programs that focus on the management of oral oncolytics. The role of health care workers, including pharmacists, physicians, and nurses, is being defined as this therapeutic class grows.
Latest:
A Call to Action for Evidence-based, Outcomes-driven Conflict Management StylesWith expanding pharmacy practice, it is time to explore conflict management, and its necessity in this current climate.
Latest:
Pilot Pharmacoeconomic Analysis of Serum-derived Bovine Immunoglobulin Use in IBDThis pilot study analyzes the cost savings of utilizing a prescription medical food, serum-derived bovine immunoglobulin/protein isolate, for the management of inflammatory bowel disease in a small cohort.
Latest:
Patient Preference for Treatment Administration in Cystic FibrosisThis study assesses the preferences of patients with cystic fibrosis for treatments that differ in the mode of administration.
